A reliable estimate of SARS-CoV-2-specific antibodies is increasingly important to track the
spread of infection and define the true burden of the ongoing COVID-19 pandemic. A …

Background Many studies report the seroprevalence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antibodies. We aimed to synthesize seroprevalence data to …

We estimated the seroprevalence of anti‐severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) antibodies in residents of African countries and explored its associated …

The extent of SARS-CoV-2 circulation in many African countries remains unclear,
underlining the need for antibody sero-surveys to assess the cumulative attack rate. Here …

Objective The objective of this study was to determine the proportion of the Anambra State
population that had been infected by the SARS-CoV-2 virus and developed antibodies …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread
globally, causing unprecedented effects on global health and economies. Community-based …

Importance The global impact of COVID-19 has led to an increased need to continuously
assess disease surveillance tools. The utility of SARS-CoV-2 serologic tools in determining …

Background: We set out to estimate the community-level exposure to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in Ghana. Methods: Phased …

Abstract Background In October 2020, after the first wave of coronavirus disease 2019
(COVID-19), only 8290 confirmed cases were reported in Kinshasa, Democratic Republic of …

Background Lebanon, a small country in the Middle East, remains severely affected by the
COVID-19 pandemic. Seroprevalence surveys of anti-SARS-CoV-2 antibodies provide …